Trader Brian Jones on Twitter: "$OVID News came out at 7:00 am stock flashed on $CNBC about a Minute later.7:00 am ET Takeda Secures Global Rights from Ovid Therapeutics to Develop/Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome(BusinessWire)" / Twitter

$OVID News came out at 7:00 am stock flashed on $CNBC about a Minute later.7:00 am ET Takeda Secures Global Rights from Ovid Therapeutics to Develop/Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome(BusinessWire)

12:18 PM · Mar 3, 2021Twitter Web App

Likes

Conversation